Peter C. Wallace
Peter C. Wallace's purchase track record
Peter C. Wallace has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 11/21/2022 | ROG | $300K | +43.0% | +56.3% | +6.1% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Curtiss-Wright (CW) Eyes Earnings Beat, Adds Nuclear Simulator. Analysts are questioning whether Curtiss-Wright will again exceed earnings estimates in its upcoming report. The company also installed a Stage 1 simulator at TerraPower’s Natrium nuclear site in Kemmerer, Wyoming, highlighting its involvement in advanced reactor development. These developments keep the stock in focus as it trades near the lower end of its 52‑week range.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Roche presents new Phase III data and FDA approval. Roche reported new one-year Phase III data for vamikibart in treating uveitic macular edema, a condition causing vision loss. Additionally, the FDA approved Tecentriq for adjuvant treatment of stage III colon cancer. These developments reflect ongoing progress in the company's clinical pipeline and regulatory approvals.
Transaction History
| AIT | ▲ Buy | Grant | 4 | $1K | 9/30/2026 | View on chart |
| AIT | ▼ Sell | Open Market | 1,904 | $648K | 8/26/2026 | View on chart |
| AIT | ▼ Sell | Other | 584 | $191K | 7/12/2026 | View on chart |
| AIT | ▼ Sell | Other | 584 | $191K | 7/12/2026 | View on chart |
| AIT | ▲ Buy | Grant | 5 | $2K | 6/30/2026 | View on chart |
| CW | ▲ Buy | Grant | 221 | $159K | 6/1/2026 | View on chart |
| ROG | ▼ Sell | Open Market | 967 | $127K | 4/30/2026 | View on chart |
| ROG | ▼ Sell | Open Market | 1,430 | $190K | 4/30/2026 | View on chart |
| AIT | ▲ Buy | Grant | 6 | $2K | 3/31/2026 | View on chart |
| AIT | ▼ Sell | Open Market | 5,000 | $1.4M | 2/26/2026 | View on chart |
| ROG | ▼ Sell | Open Market | 8,000 | $859K | 2/19/2026 | View on chart |
| AIT | ▲ Buy | Grant | 688 | $0 | 1/20/2026 | View on chart |
| CW | ▲ Buy | Grant | 981 | $562K | 1/2/2026 | View on chart |
| AIT | ▲ Buy | Grant | 6 | $1K | 12/31/2025 | View on chart |
| CW | ▼ Sell | Gift | 200 | $0 | 12/11/2025 | View on chart |
| ROG | ▼ Sell | Open Market | 3,590 | $305K | 11/11/2025 | View on chart |
| ROG | ▼ Sell | Open Market | 110 | $9K | 11/10/2025 | View on chart |
| AIT | ▲ Buy | Grant | 6 | $1K | 9/30/2025 | View on chart |
| AIT | ▼ Sell | Other | 1,571 | $398K | 7/12/2025 | View on chart |
| AIT | ▼ Sell | Other | 1,571 | $398K | 7/12/2025 | View on chart |
| AIT | ▲ Buy | Grant | 10 | $2K | 6/30/2025 | View on chart |
| CW | ▲ Buy | Grant | 221 | $98K | 6/2/2025 | View on chart |
| ROG | ▲ Buy | Grant | 2,760 | $0 | 5/5/2025 | View on chart |
| AIT | ▲ Buy | Grant | 9 | $2K | 3/31/2025 | View on chart |
| AIT | ▲ Buy | Grant | 684 | $0 | 1/23/2025 | View on chart |
| AIT | ▲ Buy | Grant | 6 | $2K | 12/31/2024 | View on chart |
| AIT | ▲ Buy | Grant | 9 | $2K | 9/30/2024 | View on chart |
| AIT | ▼ Sell | Other | 1,560 | $304K | 7/12/2024 | View on chart |
| AIT | ▼ Sell | Other | 1,560 | $304K | 7/12/2024 | View on chart |
| AIT | ▲ Buy | Grant | 12 | $2K | 6/30/2024 | View on chart |
| ROG | ▲ Buy | Grant | 1,500 | $0 | 5/2/2024 | View on chart |
| AIT | ▲ Buy | Grant | 12 | $2K | 3/31/2024 | View on chart |
| AIT | ▲ Buy | Grant | 1,035 | $0 | 1/23/2024 | View on chart |
| AIT | ▲ Buy | Grant | 14 | $2K | 12/31/2023 | View on chart |
| AIT | ▼ Sell | Open Market | 1,130 | $184K | 11/24/2023 | View on chart |
| AIT | ▲ Buy | Option Exercise | 1,130 | $46K | 11/24/2023 | View on chart |
| AIT | ▲ Buy | Option Exercise | 1,984 | $81K | 11/20/2023 | View on chart |
| AIT | ▼ Sell | Open Market | 1,984 | $323K | 11/20/2023 | View on chart |
| AIT | ▲ Buy | Grant | 14 | $2K | 9/30/2023 | View on chart |
| AIT | ▼ Sell | Other | 1,546 | $229K | 7/12/2023 | View on chart |
| AIT | ▼ Sell | Other | 1,546 | $229K | 7/12/2023 | View on chart |
| AIT | ▲ Buy | Grant | 22 | $3K | 6/30/2023 | View on chart |
| ROG | ▲ Buy | Grant | 1,050 | $0 | 5/4/2023 | View on chart |
| AIT | ▲ Buy | Grant | 19 | $3K | 3/31/2023 | View on chart |
| AIT | ▲ Buy | Grant | 1,211 | $0 | 1/24/2023 | View on chart |
| AIT | ▲ Buy | Grant | 20 | $3K | 12/31/2022 | View on chart |
| ROG | ▲ Buy | Open Market | 1,000 | $100K | 11/22/2022 | View on chart |
| ROG | ▲ Buy | Open Market | 2,000 | $200K | 11/21/2022 | View on chart |
| AIT | ▲ Buy | Grant | 25 | $3K | 9/30/2022 | View on chart |
| AIT | ▼ Sell | Other | 1,527 | $142K | 7/12/2022 | View on chart |
| AIT | ▼ Sell | Other | 1,527 | $142K | 7/12/2022 | View on chart |
| AIT | ▲ Buy | Grant | 30 | $3K | 6/30/2022 | View on chart |
| AIT | ▼ Sell | Open Market | 5,000 | $542K | 5/17/2022 | View on chart |
| ROG | ▲ Buy | Grant | 600 | $0 | 5/5/2022 | View on chart |
| AIT | ▲ Buy | Option Exercise | 2,641 | $116K | 5/3/2022 | View on chart |
| AIT | ▲ Buy | Option Exercise | 2,290 | $107K | 5/3/2022 | View on chart |
| AIT | ▼ Sell | Open Market | 4,931 | $518K | 5/3/2022 | View on chart |
| AIT | ▲ Buy | Grant | 31 | $3K | 3/31/2022 | View on chart |
| AIT | ▲ Buy | Grant | 1,471 | $0 | 1/25/2022 | View on chart |
| AIT | ▲ Buy | Grant | 32 | $3K | 12/31/2021 | View on chart |
| AIT | ▲ Buy | Grant | 34 | $3K | 9/30/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
AIT Q4 2026 Earnings Call Transcript Released
Applied Industrial Technologies released the transcript for its Q4 2026 earnings call, providing detailed insights into recent performance. This follows a period where the stock has shown strength relative to some industrial peers. The release offers investors a direct look at management's commentary on factory order trends and operational updates.
AIT Q4 2026 Earnings Call Transcript Released. Applied Industrial Technologies released the transcript for its Q4 2026 earnings call, providing detailed insights into recent performance. This follows a period where the stock has shown strength relative to some industrial peers. The release offers investors a direct look at management's commentary on factory order trends and operational updates.